您的位置: 首页 > 农业专利 > 详情页

Contrast agent to assess quality of occlusion through impedance measurement
专利权人:
Medtronic CryoCath LP
发明人:
Nicolas Coulombe,Jean-Pierre Lalonde
申请号:
US14689180
公开号:
US09956025B2
申请日:
2015.04.17
申请国别(地区):
US
年份:
2018
代理人:
摘要:
A method, system, and device for predicting lesion quality. Specifically, lesion quality may be predicted based on an assessment of pulmonary vein occlusion using injection of an impedance-modifying agent and evaluation of changes in impedance measurements recorded by an electrode located distal to an occlusion element of the treatment device used to inject the impedance-modifying agent. The quality of the occlusion may be rated based on the changes in impedance over time within the pulmonary vein. For example, the quality of the occlusion may be rated as being good, fair, or poor. This assessment may be quickly and easily communicated to an operator.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充